<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951409/" ref="ordinalpos=1945&amp;ncbi_uid=2518568&amp;link_uid=PMC2951409" image-link="/pmc/articles/PMC2951409/figure/fig05/" class="imagepopup">Fig. 5. From: WASP is activated by phosphatidylinositol-4,5-bisphosphate to restrict synapse growth in a <span class="highlight" style="background-color:">pathway</span> parallel to bone morphogenetic protein <span class="highlight" style="background-color:">signaling</span>. </a></div><br /><div class="p4l_captionBody">Tweek acts in WSP and NWK signaling. (A–C) NMJs labeled with anti-HRP in controls (A), tweek mutants that neuronally express PLCδ1-PHS39R-GFP (B), and tweek mutants that express PLCδ1- PH-GFP (C). (D–F) NMJ labeling with anti-HRP in tweek;wsp double mutants (D), in tweek;nwk double mutants (E), and in nwk wsp double mutants neuronally expressing PLCδ1-PH-GFP (F). (G) Quantification of data shown in A–F. Error bars indicate SEM; ***P &lt; 0.001; n is indicated in the bars; ns, not significant. (H) Model of the genetic pathway encompassing Tweek, NWK, and WSP (Wasp).</div></div>